Inactive Instrument

Press Releases BioAdaptives, Inc. Other OTC

Equities

BDPT

US09072U1079

Press Releases

Unlock all the news: Be the first to know and act before the market!

BioAdaptives, Inc. Welcomes Gimhana Dissanayake to Its Board of Directors	30/05	AQ
BioAdaptives : Appoints James Keener as New CEO to Lead Strategic Growth Initiatives - Form 8-K	22/05	PU
BioAdaptives, Inc. Appoints James Keener as New CEO to Lead Strategic Growth Initiatives	21/05	AQ
BioAdaptives, Inc. Announces NaturaComplete™, an All-In-One Supplement to Optimize Its AI-Based FYO Obesity Management System	22/02	AQ
BioAdaptives Announces Low-Cost AI FYO Smartphone App Tracking System to Detect Unwanted Muscle Mass Loss Reported With Obesity Management	01/02	AQ
BioAdaptives Announces Signing of a New Distributor’s Agreement for AI Body Composition Measuring App and New Weight Management System	17/01	AQ
Livestock Impact, Inc., Subsidiary of BioAdaptives, Inc., Launches Innovative Food Lab for Development of Treats and Supplement Powder for Human, Equine, and Canine Products	04/01	AQ
BioAdaptives, Inc. to Form New Division, AI BodyShape Lab, to Promote Adult Fitness and Weight Management	21/12	AQ
BioAdaptives, Inc. Introduces PROTEINnMORETM Ahead of 2024 Launch of AI-based “Fit Your Outfit” app	14/12	AQ
BioAdaptives Announces Special Holiday Wellness Offers and Gift	07/12	AQ
BioAdaptives Announces the Development of VeganHepPlusTM Liver Supplement Formula	16/11	AQ
BioAdaptives Highlights Continued Success of Popular LUNG ARMOR™ System as US Enters Flu Season	09/11	AQ
BioAdaptives Takes Aim at Safe Pain Management with All-Natural Supplement	02/11	AQ
BioAdaptives Targets Multi-Billion Dollar Sleep Market with SleepEZ™ Natural Supplement	26/23/26	AQ
BioAdaptives, Inc. Celebrates Nine Years of Commercial Success in Equine Nutrition	12/23/12	AQ
BioAdaptives, Inc. Commences Development of a New Supplement for Women’s Health	05/23/05	AQ
BioAdaptives, Inc. Redefines Its Expanding Role of Providing Innovative Human Health Products While Its Wholly Owned Subsidiary, LiveStock Impact, Inc., Targets Animal Health and Botanical Drugs	27/23/27	AQ
LiveStock Impact, Inc., a Wholly Owned Subsidiary of BioAdaptives, Inc., Announces the Appointments of two Experts to Board of Directors	14/23/14	AQ
Sub-Penny Stock Momentum List (EPAZ, BDPT, SHMN, MRNJ)	12/23/12	AQ
BioAdaptives, Inc. Announces the Spin-off Its LiveStock Impact Division as a Wholly Owned Subsidiary, LiveStock Impact, Inc., Focusing on New Product Development and Global Marketing of Animal Health Supplement Products and Botanical Drugs	08/23/08	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases BioAdaptives, Inc. Other OTC

Equities

BDPT

US09072U1079

Press Releases

Filters